Cleavage of CD14 on human gingival fibroblasts cocultured with activated neutrophils is mediated by human leukocyte elastase resulting in down-regulation of lipopolysaccharide-induced IL-8 production.
Activated polymorphonuclear leukocytes (PMNs) release various types of proteases and express them on the cell surface. The proteases play important roles in PMN-mediated events. In the present study, flow cytometric analysis revealed that CD14 expression on human gingival fibroblasts (HGF) was markedly reduced by PMA-activated PMNs in a coculture system. We found that this reduction was caused by both secreted and cell surface proteases produced by activated PMNs. A protease responsible for the reduction was found to be human leukocyte elastase (HLE) secreted from the activated PMNs by use of various protease inhibitors, although HLE was only partially involved in CD14 reduction caused by cell-bound molecule(s) on fixed PMNs. Analysis with purified HLE revealed a time- and dose-dependent reduction of CD14 on HGF, and complete reduction was observed by 20 microg/ml HLE treatment for 30-60 min, but the other molecules such as CD26, CD59, CD157, and MHC class I on HGF were only slightly reduced. This reduction of CD14 resulted from direct proteolysis by HLE on the cell surface, because HLE reduced CD14 on fixed HGF and also on purified cell membranes. As a result of CD14 proteolysis, IL-8 production by HGF was suppressed when triggered by 10 ng/ml LPS, but not by IL-1alpha, indicating that HLE inhibited a CD14-dependent cell activation. These findings suggested that activated PMNs have a potential negative feedback mechanism for HGF function at the inflammatory site, particularly in periodontal tissues.
Nemoto
E
E
Division of Periodontics and Endodontics, Tohoku University Graduate School of Dentistry, Sendai, Japan. eiji@mail.cc.tohoku.ac.jp
Sugawara
S
S
Tada
H
H
Takada
H
H
Shimauchi
H
H
Horiuchi
H
H
D000293:Adolescent; D000328:Adult; D002478:Cells, Cultured; D002648:Child; D018920:Coculture Techniques; D015536:Down-Regulation / Q000276:immunology*; D005347:Fibroblasts / Q000166:cytology / Q000276:immunology* / Q000378:metabolism; D005404:Fixatives; D005557:Formaldehyde; D005881:Gingiva / Q000166:cytology / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D006868:Hydrolysis; D016209:Interleukin-8 / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D019272:Leukocyte Elastase / Q000494:pharmacology / Q000502:physiology*; D018950:Lipopolysaccharide Receptors / Q000096:biosynthesis / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D018375:Neutrophil Activation / Q000187:drug effects / Q000276:immunology; D009504:Neutrophils / Q000187:drug effects / Q000201:enzymology / Q000276:immunology* / Q000378:metabolism; D011108:Polymers; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology
D005404:Fixatives; D016209:Interleukin-8; D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides; D011108:Polymers; D015842:Serine Proteinase Inhibitors; D005557:Formaldehyde; D019272:Leukocyte Elastase; C003043:paraform